Loyal
12 known investors
Loyal develops therapeutics to help dogs live longer and healthier lives, focusing on canine aging research and longevity interventions for companion dogs.
Founders & leadership
CH
Investors · 12
age1San Francisco · $500K – $4M
Collaborative FundNew York · $500K – $1M
Collaborative Fund (Collab Fund)New York
First Round CapitalSan Francisco · $2M
Flucas VenturesJupiter · $100K – $5Mvia Ashley Flucas · inferred
Khosla VenturesMenlo Park · $5K – $50M
MetaplanetTallinn · $500K – $10M
Shrug CapitalSunnyvale · $100K – $3Mvia Niv Dror · inferred
Todd and Rahul’s Angel FundSan Francisco · $300K – $500K
Village GlobalCovina · $100K – $500K
Baillie GiffordreportedEdinburgh
Refactor CapitalreportedBurlingame · $1M – $2M
In the news
- Loyal raises $100 million for dog longevity drugs - Bizwomenbizjournals.com · 2026
- Loyal Raises $100M Series C to Advance First Canine Longevity Drugpetage.com · 2026
- Loyal Raises $100M Series C, Led by age1, to Advance the First Canine Longevity Drugbusinesswire.com · 2026
- Loyal Raises $100M in Series C Fundingfinsmes.com · 2026
- Loyal raises $27M, aims to give dog owners more time with their pets | TechCrunchtechcrunch.com · 2021
- Loyal’s Series C: $100M to advance the first longevity drugloyal.com · 2020